• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 microRNA-486 和 microRNA-146a 可作为老年人肌少症的潜在生物标志物。

Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults.

机构信息

Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital, Bei-Hu Branch, Taipei, Taiwan.

Graduate Institute of Rehabilitation Science, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.

出版信息

BMC Geriatr. 2021 Jan 30;21(1):86. doi: 10.1186/s12877-021-02040-0.

DOI:10.1186/s12877-021-02040-0
PMID:33516190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7847166/
Abstract

BACKGROUND

Age-related sarcopenia meaningfully increases the risks of functional limitations and mortality in the older adults. Although circulating microRNAs (c-miRNAs) are associated with aging-related cellular senescence and inflammation, the relationships between c-miRNAs and sarcopenia in the older adults remain unclear. This study investigates whether circulating myo-miRNAs and inflammation-related miRNAs are associated with sarcopenia in the older adults.

METHODS

This investigation recruited 77 eligible subjects (41 males and 36 females) from 597 community-dwelling older adults, and then divided them into normal (n = 24), dynapenic (loss of muscular function without mass, n = 35), and sarcopenic groups (loss of muscular function with mass, n = 18). Moreover, myo- (c-miRNA-133a and c-miRNA-486) and inflammation- (c-miRNA-21 and c-miRNA-146a) related miRNAs, as well as, inflammatory-related cytokine and peroxide levels in plasma were determined using quantitative polymerase chain reaction and ELISA, respectively.

RESULTS

Sarcopenic group exhibited lesser skeletal muscle mass index (SMI), handgrip strength, and gait speed, as well as, lower c-miR-486 and c-miR-146a levels, compared to those of normal and dynapenic groups. Moreover, c-miR-486 level was positively related to SMI (r = 0.334, P = 0.003), whereas c-miR-146a level was positively associated with SMI (r = 0.240, P = 0.035) and handgrip strength (r = 0.253, P = 0.027). In the receiver operating characteristic analysis for predicting sarcopenia, the area under the curve in c-miR-486 was 0.708 (95% confidence interval: 0.561-0.855, P = 0.008) and c-miR-146a was 0.676 (95% CI: 0.551-0.801, P = 0.024). However, no significant relationships were observed between SMI/handgrip strength/gait speed and plasma myeloperoxidase/interleukin-1훽/interleukin-6 levels.

CONCLUSIONS

Myo-miRNA (c-miR-486) and inflammation-related miRNA (c-miR-146a) are superior to inflammatory peroxide/cytokines in plasma for serving as critical biomarkers of age-related sarcopenia.

摘要

背景

与年龄相关的肌肉减少症显著增加了老年人功能受限和死亡的风险。虽然循环 microRNAs(c-miRNAs)与衰老相关的细胞衰老和炎症有关,但 c-miRNAs 与老年人肌肉减少症之间的关系仍不清楚。本研究调查了循环肌源性 miRNAs 和炎症相关 miRNAs 是否与老年人的肌肉减少症有关。

方法

本研究从 597 名社区居住的老年人中招募了 77 名符合条件的受试者(41 名男性和 36 名女性),并将他们分为正常组(n=24)、动力减少组(肌肉功能丧失而无质量减少,n=35)和肌肉减少症组(肌肉功能丧失伴质量减少,n=18)。此外,使用定量聚合酶链反应和 ELISA 分别测定了肌源性(c-miRNA-133a 和 c-miRNA-486)和炎症相关(c-miRNA-21 和 c-miRNA-146a)miRNAs 以及血浆中炎症相关细胞因子和过氧化物水平。

结果

与正常组和动力减少组相比,肌肉减少症组的骨骼肌质量指数(SMI)、握力和步态速度较低,c-miR-486 和 c-miR-146a 水平也较低。此外,c-miR-486 水平与 SMI 呈正相关(r=0.334,P=0.003),而 c-miR-146a 水平与 SMI(r=0.240,P=0.035)和握力(r=0.253,P=0.027)呈正相关。在 c-miR-486 预测肌肉减少症的受试者工作特征分析中,曲线下面积为 0.708(95%置信区间:0.561-0.855,P=0.008),c-miR-146a 为 0.676(95%CI:0.551-0.801,P=0.024)。然而,SMI/握力/步态速度与血浆髓过氧化物酶/白细胞介素-1β/白细胞介素-6 水平之间没有显著关系。

结论

肌源性 miRNA(c-miR-486)和炎症相关 miRNA(c-miR-146a)优于血浆中的炎症过氧化物/细胞因子,可作为与年龄相关的肌肉减少症的关键生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/66780982d50f/12877_2021_2040_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/ff9fc2bdc5ec/12877_2021_2040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/55ea13d820ad/12877_2021_2040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/054de05e24f9/12877_2021_2040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/539bbcd01875/12877_2021_2040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/66780982d50f/12877_2021_2040_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/ff9fc2bdc5ec/12877_2021_2040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/55ea13d820ad/12877_2021_2040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/054de05e24f9/12877_2021_2040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/539bbcd01875/12877_2021_2040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7847166/66780982d50f/12877_2021_2040_Fig5_HTML.jpg

相似文献

1
Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults.循环 microRNA-486 和 microRNA-146a 可作为老年人肌少症的潜在生物标志物。
BMC Geriatr. 2021 Jan 30;21(1):86. doi: 10.1186/s12877-021-02040-0.
2
Plasma microRNA signature associated with skeletal muscle wasting in post-menopausal osteoporotic women.与绝经后骨质疏松症妇女骨骼肌减少相关的血浆 microRNA 特征。
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):690-701. doi: 10.1002/jcsm.13421. Epub 2024 Jan 25.
3
Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly.老年人血浆中循环微RNA水平随肌肉减少症而降低。
Front Genet. 2020 Mar 5;11:167. doi: 10.3389/fgene.2020.00167. eCollection 2020.
4
Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure.循环 microRNAs 作为慢性心力衰竭加速性肌少症的生物标志物。
Glob Heart. 2021 Aug 30;16(1):56. doi: 10.5334/gh.943. eCollection 2021.
5
Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.北京80岁及以上男性的肌肉减少症和肌肉减少性肥胖:患病率及其与功能表现的关联
Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:29-35. doi: 10.1111/ggi.12211.
6
Circulatory microRNAs are not effective biomarkers of muscle size and function in middle-aged men.循环 microRNAs 不是中年男性肌肉大小和功能的有效生物标志物。
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C293-C298. doi: 10.1152/ajpcell.00395.2018. Epub 2019 Jan 2.
7
Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status.基于骨质疏松症和肌肉减少症状况的绝经后妇女的骨和肌肉特异性循环 microRNAs。
Bone. 2019 Mar;120:271-278. doi: 10.1016/j.bone.2018.11.001. Epub 2018 Nov 5.
8
Vitamin D Deficiency and Molecular Changes in Circulating MicroRNAs in Older Adults with Lower Back Pain.维生素 D 缺乏与老年腰痛患者循环 microRNAs 的分子变化。
Pain Res Manag. 2021 May 17;2021:6662651. doi: 10.1155/2021/6662651. eCollection 2021.
9
Circulating miRNA-1-3p as Biomarker of Accelerated Sarcopenia in Patients Diagnosed with Chronic Heart Failure.循环 miRNA-1-3p 作为诊断为慢性心力衰竭患者的加速性骨骼肌减少症的生物标志物。
Rev Invest Clin. 2022;74(5):276-268. doi: 10.24875/RIC.22000151.
10
The Severity of Muscle Performance Deterioration in Sarcopenia Correlates With Circulating Muscle Tissue-Specific miRNAs.肌肉减少症中肌肉性能恶化的严重程度与循环肌肉组织特异性 miRNAs 相关。
Physiol Res. 2021 Nov 30;70(Suppl 1):S91-S98.

引用本文的文献

1
Circulating miR-144-3p as a Novel Independent Biomarker Associated With Low Muscle Strength Among Older Adults.循环miR-144-3p作为老年人肌肉力量低下相关的新型独立生物标志物
J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70026. doi: 10.1002/jcsm.70026.
2
Pathophysiological Mechanisms Underlying Sarcopenia and Sarcopenic Obesity: A Systematic Review and Meta-Analysis of Biomarker Evidence.肌肉减少症和肌肉减少性肥胖的病理生理机制:生物标志物证据的系统评价和荟萃分析
Int J Mol Sci. 2025 May 26;26(11):5113. doi: 10.3390/ijms26115113.
3
The emerging role of miRNAs in biological aging and age-related diseases.

本文引用的文献

1
Sarcopenia.肌肉减少症。
Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3.
2
Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.抑制白细胞介素-1受体相关激酶1(IRAK1)作为一种治疗策略。
Oncotarget. 2018 Sep 7;9(70):33416-33439. doi: 10.18632/oncotarget.26058.
3
Skeletal muscle performance and ageing.骨骼肌性能与衰老。
微小RNA在生物衰老及与年龄相关疾病中的新作用。
Noncoding RNA Res. 2025 May 5;13:131-152. doi: 10.1016/j.ncrna.2025.05.002. eCollection 2025 Aug.
4
Towards Precision in Sarcopenia Assessment: The Challenges of Multimodal Data Analysis in the Era of AI.迈向肌肉减少症评估的精准化:人工智能时代多模态数据分析的挑战
Int J Mol Sci. 2025 May 7;26(9):4428. doi: 10.3390/ijms26094428.
5
A framework of biomarkers for skeletal muscle aging: a consensus statement by the Aging Biomarker Consortium.骨骼肌衰老生物标志物框架:衰老生物标志物联盟的共识声明
Life Med. 2025 Jan 26;3(6):lnaf001. doi: 10.1093/lifemedi/lnaf001. eCollection 2024 Dec.
6
Adipose-derived exosomes ameliorate skeletal muscle atrophy via miR-146a-5p/IGF-1R signaling.脂肪源性外泌体通过miR-146a-5p/IGF-1R信号通路改善骨骼肌萎缩。
J Nanobiotechnology. 2024 Dec 18;22(1):754. doi: 10.1186/s12951-024-02983-7.
7
Muscle-enriched microRNA-486-mediated regulation of muscular atrophy and exercise.肌肉富集的微小RNA-486介导的肌肉萎缩与运动调节
J Physiol Biochem. 2024 Nov;80(4):795-809. doi: 10.1007/s13105-024-01043-w. Epub 2024 Sep 2.
8
Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.脓毒症生物标志物:进展与临床应用——叙述性综述。
Int J Mol Sci. 2024 Aug 19;25(16):9010. doi: 10.3390/ijms25169010.
9
Association of interleukin-6 with sarcopenia and its components in older adults: a systematic review and meta-analysis of cross-sectional studies.白细胞介素-6 与老年人肌肉减少症及其成分的相关性:横断面研究的系统评价和荟萃分析。
Ann Med. 2024 Dec;56(1):2384664. doi: 10.1080/07853890.2024.2384664. Epub 2024 Aug 22.
10
Sustainability of exercise-induced benefits on circulating MicroRNAs and physical fitness in community-dwelling older adults: a randomized controlled trial with follow up.运动诱导的循环 MicroRNAs 变化及其对社区老年人身体适应性影响的可持续性:一项随机对照试验及随访研究
BMC Geriatr. 2024 May 30;24(1):473. doi: 10.1186/s12877-024-05084-0.
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):3-19. doi: 10.1002/jcsm.12238. Epub 2017 Nov 19.
4
Targeting mitochondrial function and proteostasis to mitigate dynapenia.针对线粒体功能和蛋白质稳态来缓解动力不足。
Eur J Appl Physiol. 2018 Jan;118(1):1-9. doi: 10.1007/s00421-017-3730-x. Epub 2017 Oct 6.
5
Circulating MiRNAs as biomarkers of gait speed responses to aerobic exercise training in obese older adults.循环微RNA作为肥胖老年人有氧运动训练步态速度反应生物标志物的研究
Aging (Albany NY). 2017 Mar 15;9(3):900-913. doi: 10.18632/aging.101199.
6
Pathogenesis and Management of Sarcopenia.肌肉减少症的发病机制与管理
Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002.
7
FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification.FoxO1:对其在骨骼肌分化和纤维类型特化调控中分子机制的新见解。
Oncotarget. 2017 Feb 7;8(6):10662-10674. doi: 10.18632/oncotarget.12891.
8
Examining how p16(INK4a) expression levels are linked to handgrip strength in the elderly.检测老年人中 p16(INK4a)表达水平与握力的关系。
Sci Rep. 2016 Aug 23;6:31905. doi: 10.1038/srep31905.
9
MicroRNA-Regulated Proinflammatory Cytokines in Sarcopenia.肌肉减少症中微小RNA调控的促炎细胞因子
Mediators Inflamm. 2016;2016:1438686. doi: 10.1155/2016/1438686. Epub 2016 Jun 13.
10
MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.微小RNA-146a和微小RNA-146b通过靶向TRAF6和IRAK1蛋白来调节人类树突状细胞的凋亡和细胞因子产生。
J Biol Chem. 2015 Jan 30;290(5):2831-41. doi: 10.1074/jbc.M114.591420. Epub 2014 Dec 11.